home / stock / pmcb / pmcb quote
Last: | $3.03 |
---|---|
Change Percent: | -56.71% |
Open: | $3.08 |
Close: | $3.03 |
High: | $3.14 |
Low: | $2.92 |
Volume: | 1,774,614 |
Last Trade Date Time: | 08/10/2021 04:41:14 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.03 | $3.08 | $3.03 | $3.14 | $2.92 | 1,774,614 | 08-10-2021 |
$7 | $9 | $7 | $10 | $6.57 | 27,350 | 08-09-2021 |
$0.0093 | $0.0092 | $0.0093 | $0.0094 | $0.0092 | 604,041 | 07-09-2021 |
$0.0093 | $0.0093 | $0.0093 | $0.01 | $0.009 | 3,429,775 | 07-08-2021 |
$0.0092 | $0.0093 | $0.0092 | $0.011 | $0.009 | 3,477,194 | 07-07-2021 |
$0.0099 | $0.01015 | $0.0099 | $0.014 | $0.0091 | 16,117,471 | 07-06-2021 |
$0.0105 | $0.00964 | $0.0105 | $0.0106 | $0.0093 | 3,595,116 | 07-05-2021 |
$0.0105 | $0.00964 | $0.0105 | $0.0106 | $0.0093 | 3,595,116 | 07-02-2021 |
$0.0097 | $0.0092 | $0.0097 | $0.011 | $0.0091 | 4,866,844 | 07-01-2021 |
$0.0108 | $0.01 | $0.0108 | $0.0108 | $0.009 | 6,006,989 | 06-30-2021 |
$0.0105 | $0.012 | $0.0105 | $0.012 | $0.0096 | 7,114,367 | 06-29-2021 |
$0.0112 | $0.014 | $0.0112 | $0.0143 | $0.0101 | 6,475,711 | 06-28-2021 |
$0.013 | $0.01375 | $0.013 | $0.0138 | $0.0128 | 5,150,959 | 06-25-2021 |
$0.0133 | $0.013 | $0.0133 | $0.014 | $0.0125 | 4,088,254 | 06-24-2021 |
$0.012 | $0.0089 | $0.012 | $0.0135 | $0.0087 | 13,522,811 | 06-23-2021 |
$0.0086 | $0.0071 | $0.0086 | $0.0086 | $0.0071 | 9,706,518 | 06-22-2021 |
$0.0075 | $0.007 | $0.0075 | $0.008 | $0.0069 | 10,072,442 | 06-21-2021 |
$0.0069 | $0.0087 | $0.0069 | $0.0087 | $0.0068 | 42,754,343 | 06-18-2021 |
$0.0087 | $0.0112 | $0.0087 | $0.0112 | $0.0075 | 40,563,859 | 06-17-2021 |
$0.0112 | $0.0115 | $0.0112 | $0.0115 | $0.0097 | 20,228,619 | 06-16-2021 |
News, Short Squeeze, Breakout and More Instantly...
PharmaCyte Biotech Inc. Company Name:
PMCB Stock Symbol:
OTCMKTS Market:
PharmaCyte Biotech Inc. Website:
Epiroc AB ADR (EPOKY) is expected to report for Q3 2023 Sysmex Corporation ADR (SSMXY) is expected to report for Q2 2024 Streamline Health Solutions Inc. (STRM) is expected to report for Q1 2024 Helix Biopharma Corp. (HBPCF) is expected to report for Q2 2024 Standard Chartered plc...